CN Patent

CN101340884A — 用于治疗多汗症的方法

Assigned to Individual · Expires 2009-01-07 · 17y expired

What this patent protects

本发明总的来说涉及治疗出汗疾患的方法，特别是涉及用于治疗多汗症的局部用组合物。本发明的方法涉及组合物的局部应用，该组合物包含治疗上有效量的奥昔布宁、托特罗定或取代的苯甲酰胺如舒必利。

USPTO Abstract

本发明总的来说涉及治疗出汗疾患的方法，特别是涉及用于治疗多汗症的局部用组合物。本发明的方法涉及组合物的局部应用，该组合物包含治疗上有效量的奥昔布宁、托特罗定或取代的苯甲酰胺如舒必利。

Drugs covered by this patent

Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical

Patent Metadata

Patent number: CN101340884A
Jurisdiction: CN
Classification: —
Expires: 2009-01-07
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.